Effective Surveillance

Antimicrobial resistance (AMR)

AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.

AMR Insights

For Officers at authorities, ministries, international organisations and NGO’s who wish to prevent the further global spreading of Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities. 

AMR Insights is for:

  • Senior officials and (top) civil servants at national authorities
  • Policy Officers at Ministries
  • Civil servants at regional authorities
  • Senior officials at international organizations
  • Senior officials at NGO’s

Latest Topics

  •   24 April 2026

    The incidence and antimicrobial resistance of Shigella-attributable diarrhoea in young children in low-income and middle-income countries from the multicountry Enterics for Global Health (EFGH) Shigella Surveillance Study: a prospective, facility-based hybrid surveillance study

    The EFGH multi-country study (2022–2024) assessed the burden, serotypes, and antimicrobial resistance of Shigella-associated diarrhoea in children aged 6–35 months across seven LMICs. Among ~9,500 children, Shigella was detected in 9% (culture) to 20% (qPCR), with Shigella flexneri—particularly serotypes 2a and 6—being dominant. Incidence rates varied substantially by country but were consistently high, confirming Shigella […]

    Read more...
  •   24 April 2026

    Prevalence of antimicrobial resistance in Tanzania: A systematic review and meta-analysis

    This systematic review and meta-analysis of 28 studies provides a comprehensive overview of antimicrobial resistance (AMR) patterns in Tanzania, revealing widespread and high resistance among clinically relevant bacterial pathogens, particularly within commonly used (Access and Watch) antibiotics. High resistance rates were observed for penicillins (notably in Klebsiella pneumoniae, Acinetobacter baumannii, and Escherichia coli), erythromycin (in […]

    Read more...
  •   24 April 2026

    Induction of colistin resistance and environmental toxicity assessment in Escherichia coli

    This study shows that repeated exposure to subinhibitory concentrations of colistin can induce clinically relevant resistance in Escherichia coli. Using a standard laboratory strain, researchers demonstrated a substantial increase in colistin MIC (from 2 to 16 mg/L) after serial low-dose exposure, alongside phenotypic expression of the mcr-1 resistance gene, comparable to a multidrug-resistant clinical isolate. […]

    Read more...

More news related to Effective surveillance

Please call me back

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!